Survival and Clinicopathologic characteristics of Meningioma

Mehrdad Roozbeh, Shokouh Taghipour zahir, Mahrooz Roozbeh, Farzan SafiDahaj

Abstract


Objectives: With the prevalence of one-third of intracranial brain tumors, Meningioma prognosis is affected by the size, location, ability to access the tumor through surgery, and the degree of histological malignancy. We intended to investigate patients' prognosis and clinical features with central nervous system meningioma.

 

Materials and Methods: Records of all patients with central nervous system and spinal cord meningiomas between 2006-2016 in Yazd Shahid Sadoughi, Shahid Rahnemoun, Mortaz, Goodarz, and Mojibian hospitals were studied. Using SPSS version 17, survival, age, type of treatment, grade, size, and tumor location were investigated in this retrospective cross-sectional study.

 

Results: Of the 175 patients (66 (37.7%) male, 109 (62.3%) female) with an average survival time of 78.5 months, tumors recurred in 12 (10.7%) patients. Among them, 63 (47%) were between 18-54, and 72 (53%) were between 55-87 years. Syncytial was the most common histological subtype, and a significant relationship between age and tumor subtype was found (p-value = 0.03). Primary symptoms of headache and nausea/vomiting were in most of them (51, 57%). The most and the most minor expected location was the brain lobes (14 cases) and the spinal cord (2 patients). There was no significant relationship between meningioma subtype-symptoms, survival-gender/ tumor subtype, recurrence-gender/ age, or tumor subtype. Also, a significant relationship between age and survival was found (p-value = 0.05).

 

Conclusion: An increase in the prevalence of meningioma in recent years has been due to improvements in imaging techniques and the population's aging. Overall, there was a significant relationship between age and meningioma prevalence.


Keywords


Meningioma, brain tumor, survival, recurrence

Full Text:

PDF

References


Alruwaili AA, De Jesus O. Meningioma. [Updated 2021 Sep 15]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560538/

Kamenova M, Guzman R, Soleman J. Demographics and outcome of histologically confirmed intracranial meningiomas. Clin Transl Neurosci 2019;3(2):2514183X19894945

Huntoon K, Toland AMS, Dahiya S. Meningioma: A Review of Clinicopathological and Molecular Aspects. Front Oncol 2020;10:579599. doi: 10.3389/fonc.2020.579599

Riemenschneider MJ, Perry A, Reifenberger G. Histological classification and molecular genetics of meningiomas. Lancet Neurol 2006;5(12):1045–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17110285

Aster JC, Abbas AK. Robbins basic pathology. Philadelphia, PA: Elsevier Saunders; 2013.

Wanis HA, Møller H, Ashkan K, et al. The incidence of major subtypes of primary brain tumors in adults in England 1995-2017. Neuro Oncol 2021;23(8):1371-1382. doi: 10.1093/neuonc/noab076

Ostrom QT, Francis SS, Barnholtz-Sloan JS. Epidemiology of Brain and Other CNS Tumors. Curr Neurol Neurosci Rep 2021;21(12):68. doi: 10.1007/s11910-021-01152-9. PMID: 34817716; PMCID: PMC8613072.

Miller KD, Ostrom QT, Kruchko C, et al. Brain and other central nervous system tumor statistics. CA Cancer J Clin 2021;71(5):381-406. doi: 10.3322/caac.21693

Garzon-Muvdi T, Yang W, Lim M, et al. Atypical and anaplastic meningioma: outcomes in a population-based study. J Neurooncol 2017;133(2):321–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28429237

Fonkem E, Dandashi JA, Stroberg E, et al. A retrospective analysis of meningioma in Central Texas. J Epidemiol Glob Health 2016;6(2):87–93. Available from: https://www.sciencedirect.com/science/article/pii/S2210600616000022

Chebil C, Boumediene F, Cicero CE, et al. Epidemiology of Primary Brain Tumors in the Province of Catania during the 2003-2016 Period. Neuroepidemiology 2021;55(6):473-483. doi: 10.1159/000519512

Barresi V, Caffo M, Tuccari G. Classification of human meningiomas: lights, shadows, and future perspectives. J Neurosci Res 2016;94(12):1604–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27376782

Mehrazin M, Rahmat H, Yavari P. Epidemiology of primary intracranial tumors in Iran, 1978-2003. Asian Pac J Cancer Prev 2006;7(2):283.

Bitaraf MA, Azar M, Miri SM, et al. Radiosurgery for skull base meningiomas: a study on 230 cases in Iranian Gamma Knife Center. Tehran Univ Med J 2010;68(3):162-167 (In Persian). Available from: http://tumj.tums.ac.ir/article-1-360-fa.html

Faraji M, Birjandi A. Pediatric Meningioma. OFOGH-E-DANESH 2004;10(1):14-17 (In Persian). Available from: http://fa.journals.sid.ir/ViewPaper.aspx?id=18674

Samadi N, Ahmadi SA. Meningioma: a clinicopathological evaluation. Malays J Med Sci 2007;14(1):46-52. PMID: 22593651; PMCID: PMC3351217.

Shiravi Khozani M, Moradi A, Solat Yekani S F, et al. Pathologic study of Ki-67 and p53 protein expression in patients with meningioma referred to Shohadaye- Tajrish hospital. Research in Medicine 2013;37(2):102-106 (In Persian). Available from: http://pejouhesh.sbmu.ac.ir/article-1-1187-fa.html

Taghipour M, Razmkon A, Bakhtazad A. High prevalence of intracranial meningioma in Jewish population in Shiraz, Southern Iran. Neurosurg Q 2010;20(2):68-70. doi: 10.1097/WNQ.0b013e3181dcb220.

Zakarian B, Tonkaboni JS. Meningioma in a dog in Iran: a case report, together with a review of the literature and special reference to the aetiology. J Small Anim Pract 1971;12(1):37-43.

Mashayekhi F, Saberi A, Mashayekhi S. Serum TIMP1 and TIMP2 concentration in patients with different grades of meningioma. Clin Neurol Neurosurg 2018;170:84-7. doi: 10.1016/j.clineuro.2018.05.001

Da Broi M, Borrelli P, Meling TR. Predictors of Survival in Atypical Meningiomas. Cancers (Basel) 2021;13(8):1970. doi: 10.3390/cancers13081970. PMID: 33919475; PMCID: PMC8074901.

Ogasawara C, Philbrick BD, Adamson DC. Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions. Biomedicines 2021;9(3):319. doi: 10.3390/biomedicines9030319. PMID: 33801089; PMCID: PMC8004084.

Farokhi MR, Ansari Z. Recurrence Of Intracranial Meningioma And Its Contributive Factors; A 20- Year Study. Tehran Univ Med J 2007;65(12):91-96.

Fonkem E, Dandashi JA, Stroberg E, et al. A retrospective analysis of meningioma in Central Texas. J Epidemiol Glob Health 2016;6(2):87–93. doi: 10.1016/j.jegh.2016.01.001

Zahir ST, Vakili M, Navabii H. Clinicopathological Findings and Five-Year Survival Rates for Patients with Central Nervous System Tumors in Yazd, Iran 2014;15:10319–23.

Komori T. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision. Neurol Med Chir (Tokyo) 2017;57(7):301–11.

Perry A, Stafford SL, Scheithauer BW, et al. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 1997;21(12):1455–65.

Bhat AR, Wani MA, Kirmani AR, Ramzan AU. Histological-subtypes and anatomical location correlated in meningeal brain tumors (meningiomas). J Neurosci Rural Pract 2014;5(3):244–9.

Jordan JT, Plotkin SR. Benign Intracranial Tumors. Neurol Clin 2018;36(3):501–16.

Kuratsu J, Ushio Y. Epidemiological study of primary intracranial tumours in elderly people. J Neurol Neurosurg Psychiatry 1997;63(1):116–8.

Kshettry VR, Hsieh JK, Ostrom QT, et al. Descriptive epidemiology of spinal meningiomas in the United States. Spine (Phila Pa 1976) 2015;40(15):E886–9.

Zouaoui S, Darlix A, Rigau V, et al. Épidémiologie descriptive de 13 038 cas de méningiomes opérés en France entre 2006 et 2010. Neurochirurgie 2018;64(1):15–21.

Park BJ, Kim HK, Sade B, et al. Epidemiology. In: Lee JH, editor. Meningiomas: Diagnosis, Treatment, and Outcome. London: Springer-Verlag; 2009. p. 11.

Kallio M, Sankila R, Hakulinen T, et al. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 1992;31(1):2–12.

Pettersson-Segerlind J, Orrego A, Lönn S, et al. Long-term 25-year follow-up of surgically treated parasagittal meningiomas. World Neurosurg 2011;76(6):564–71. doi: 10.1016/j.wneu.2011.05.015

Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131(6):803–20.

SIMPSON D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20(1):22–39.

Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 2015;122(1):4–23.

McCarthy BJ, Davis FG, Freels S, et al. Factors associated with survival in patients with meningioma. J Neurosurg. 1998;88(5):831–9.

Das A, Tang WY, Smith DR. Meningiomas in Singapore: Demographic and biological characteristics. J Neurooncol 2000;47(2):153–60.

Therapy GR, City SL. Role of radiation therapy in treating intracranial meningiomas.

Neurosurg Focus 2007;23(4):E4.

Ikawa F, Kinoshita Y, Takeda M, et al. Review of Current Evidence Regarding Surgery in Elderly Patients with Meningioma. Neurol Med Chir (Tokyo) 2017;57(10):521-533. doi: 10.2176/nmc.ra.2017-0011.

Poon MT-C, Fung LH-K, Pu JK-S, et al. Outcome of elderly patients undergoing intracranial meningioma resection – A systematic review and meta-analysis. Br J Neurosurg 2014;28(3):303–9. doi: 10.3109/02688697.2013.841857

Rochat P, Johannesen HH, Gjerris F. Long-term follow up of children with meningiomas in Denmark: 1935 to 1984. J Neurosurg 2004;100(2 Suppl Pediatrics):179–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14758946


Refbacks

  • There are currently no refbacks.


 

Best Quality Medical Supplies is a registered company in Untied States specializing in sales of medical equipment and supplies. We are a distributor for hospitals, doctor offices, medical clinics, nursing schools, and nursing homes within the United States. We also provide services for overseas clients. Click here for details and orders .




The most affordable web hosting service. Click here for details and orders.